First, we characterized the molecular interaction of EGFR and HER2 in the membrane of SK-BR-3 mammary carcinoma cells that express these receptors at low and high levels (~80,000 and 800,000 per cell, respectively). This evidence concerns the gene EGFR and breast carcinoma.